Radioprotection of human endothelial cells with amifostine

Strahlentherapie und Onkologie

Volumn 175, Issue SUPPL.4, 1999, Pages 34-36

  Andreopoulos, Demetrios ^a   Schleicher, Ursula M ^b   Cotarelo, Christina L ^b   Hand, Stefan ^b   Ammon, Jürgen ^b  

^a Bank of Cyprus Group Oncology Centre   (Cyprus)

^b NONE

Author keywords

Amifostine; Human endothelial cells; Radioprotection

Indexed keywords

AMIFOSTINE;

ARTICLE; CELL ACTIVATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; RADIATION PROTECTION; RADIOSENSITIVITY; TUMOR GROWTH;

AMIFOSTINE; CELL DIVISION; CELLS, CULTURED; CYTOPROTECTION; ENDOTHELIUM; HUMANS; RADIATION DOSAGE; RADIATION-PROTECTIVE AGENTS; TUMOR CELLS, CULTURED;

EID: 0032721492     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. Capizzi RL. The preclinical basis for broad-spectrum selective cytoprotection of normal tissues from cytotoxic therapies by amifostine (Ethyol). Eur J Cancer 1996;32 A:Suppl 4:5-16.
2. Jaffe EA, Nachman RL, Becker CG, et al. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973;52:2745-56.
3. Porstmann T, Ternyck T, Avrameas S. Quantification of 5-bromo-2-deoxyuridine incorporation into DNA: an cnzyme immunoassay for the assessment of the lymphoid cell proliferative response. J Immunol Meth 1985;82:196-79.
4. Wasserman TH. Radiotherapeutic studies with amifostine (Ethyol). Semin Oncol 1994;21:Suppl 11:21-5.